These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 2663735)
1. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections. Beumer HM Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735 [TBL] [Abstract][Full Text] [Related]
2. Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin. Edelstein DR; Avner SE; Chow JM; Duerksen RL; Johnson J; Ronis M; Rybak LP; Bierman WC; Matthews BL; Kohlbrenner VM Laryngoscope; 1993 Jan; 103(1 Pt 1):33-41. PubMed ID: 8421417 [TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of an amoxicillin-clavulanic acid combination in respiratory tract infections]. Capecchi V Clin Ter; 1987 Feb; 120(3):211-8. PubMed ID: 2973860 [No Abstract] [Full Text] [Related]
4. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000. Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258 [TBL] [Abstract][Full Text] [Related]
5. Comparison of oral erythromycin ethylsuccinate and clavulanate-potentiated amoxicillin in the treatment of acute respiratory tract infections. Shanks N; Macklin J; Coles S Clin Ther; 1989; 11(6):812-9. PubMed ID: 2692823 [TBL] [Abstract][Full Text] [Related]
6. [Amoxicillin and clavulanic acid versus amoxicillin plus gentamicin in the empirical initial treatment of urinary tract infections in hospitalized patients]. Verzasconi R; Rodoni P; Monotti R; Marone C; Mombelli G Schweiz Med Wochenschr; 1995 Aug; 125(33):1533-9. PubMed ID: 7676242 [TBL] [Abstract][Full Text] [Related]
7. Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid. Karachalios GN Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):647-9. PubMed ID: 4093205 [TBL] [Abstract][Full Text] [Related]
8. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial. Khajotia RR; Vetter N; Harazin H Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997 [TBL] [Abstract][Full Text] [Related]
9. Once-a-day cefixime versus co-amoxiclav three times daily in the treatment of lower respiratory infections. Lieberman D; Schlaeffer F J Antimicrob Chemother; 1995 Feb; 35(2):354-7. PubMed ID: 7759403 [No Abstract] [Full Text] [Related]
10. [Controlled multicentric study comparing cefixime and amoxicillin in the treatment of lower respiratory tract infections in adults]. Hugues FC; Le Jeunne C Presse Med; 1989 Oct; 18(32):1600-4. PubMed ID: 2530542 [TBL] [Abstract][Full Text] [Related]
11. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections. Kiani R; Johnson D; Nelson B Am J Med; 1988 Sep; 85(3A):6-13. PubMed ID: 3048092 [TBL] [Abstract][Full Text] [Related]
12. [The drug combination amoxicillin-clavulanic acid compared to the triple combination ampicillin-gentamicin-metronidazole in the treatment of severe adnexal infections]. Ciraru-Vigneron N; Bercau G; Sauvanet E; Nguyen Tan Lung R; Felten A; Leaute JB; Zylbertrest T; Barrier J Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):665-8. PubMed ID: 3534764 [TBL] [Abstract][Full Text] [Related]
13. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics]. Texier-Maugein J; Escoubas J; Fouche J; Mormede M Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431 [TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and tolerance of amoxicillin/clavulanic acid ("Augmentin") in intravenous injections in adults]. el Filali KM; el M'Daghri N; el Kabli H; Hajji M; Benbachir M; Himmich H Pharmatherapeutica; 1989; 5(5):329-37. PubMed ID: 2748691 [TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis. Cazzola M; Vinciguerra A; Beghi GF; Paizis G; Giura R; Madonini V; Fiorentini F; Consigli GF; Tonna M; Casalini A J Chemother; 1995 Oct; 7(5):432-41. PubMed ID: 8596127 [TBL] [Abstract][Full Text] [Related]
16. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583 [TBL] [Abstract][Full Text] [Related]
17. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431 [TBL] [Abstract][Full Text] [Related]